Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9.

Autophagy
Marija Usenovic, Dimitri Krainc

Abstract

Neuronal homeostasis and survival critically depend on an efficient autophagy-lysosomal degradation pathway, especially since neurons cannot reduce the concentration of misfolded proteins and damaged organelles by cell division. While increasing evidence implicates lysosomal dysfunction in the pathogenesis of neurodegenerative disorders, the molecular underpinnings of the role of lysosomes in neurodegeneration remain largely unknown. To this end, studies of neurodegenerative disorders caused by mutations in lysosomal proteins offer an opportunity to elucidate such mechanisms and potentially identify specific therapeutic targets. One of these disorders is Kufor-Rakeb syndrome, caused by mutations in the lysosomal protein ATP13A2/PARK9 and characterized by early-onset Parkinsonism, pyramidal degeneration and dementia. We found that loss of ATP13A2 function results in impaired lysosomal function and, consequently, accumulation of SNCA/α-synuclein and neurotoxicity. Our results suggest that targeting of ATP13A2 to lysosomes to enhance lysosomal function may result in neuroprotection in Kufor-Rakeb syndrome. From a broader perspective, these findings, together with other recent studies of lysosomal dysfunction in neurodegeneration, ...Continue Reading

Citations

Apr 24, 2013·Nature Reviews. Molecular Cell Biology·Carmine SettembreAndrea Ballabio
Jul 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tine HolemansPeter Vangheluwe
Apr 9, 2016·Cellular Logistics·Divya KhatterMahak Sharma
May 20, 2016·Neuron·Patrick P MichelStéphane Hunot
Feb 1, 2017·Brain : a Journal of Neurology·Alejandro Estrada-CuzcanoRebecca Schüle
Jul 25, 2017·International Journal of Molecular Sciences·Myungjin KimJun Hee Lee
Mar 6, 2018·PloS One·Danny Mollerup SørensenPeter Vangheluwe
Oct 21, 2017·Molecular Neurobiology·G MorrisB K Puri
Sep 4, 2019·Nature Reviews. Drug Discovery·Srinivasa Reddy BonamSylviane Muller
Dec 13, 2018·The Journal of Cell Biology·Ruoxi WangZhuohua Zhang
Jul 16, 2019·Current Biology : CB·Soudabeh ImanikiaRebecca C Taylor
Oct 16, 2020·Nutritional Neuroscience·J B Senthil Kumar, Bhawna Sharma
Jul 2, 2021·The Journal of Clinical Investigation·Alpana SinghSubhash Kulkarni
Sep 8, 2021·Frontiers in Chemistry·Mathias BrouillardValérie Desvergnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.